To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Contaminated Nelfinavir Does Not Increase Cancer Risk, EMEA Concludes URL: http://www.pslgroup.com/dg/2264FE.htm Doctor's Guide July 24, 2008
LONDON -- July 24, 2008 -- Following a review of a number of toxicology studies, the European Medicines Agency (EMEA) confirms that there is no increased risk of developing cancer for patients who have taken nelfinavir (Viracept) contaminated with ethyl mesilate. The EMEA's Committee for Medicinal Products for Human Use (CHMP) requested a number of toxicology studies to better assess the potential harm to patients using nelfinavir contaminated with ethyl mesilate. The studies showed that it is possible to calculate a threshold value below which ethyl mesilate does not cause any mutations in the DNA. The CHMP noted that patients or children born to mothers who had taken contaminated nelfinavir were exposed to ethyl mesilate levels well below this threshold and that, therefore, there was no increased risk of developing cancer for these patients compared with those patients who were not exposed to the contaminant. The Committee therefore concluded that there was no need to monitor patients who had been exposed to high levels of contaminated nelfinavir through specific patient registries. SOURCE: The European Medicines Agency --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.